glp-1 patch clinical trial transdermal semaglutide patch Single-Administration Self-Boosting Microneedle for The Treatment of Obesity Do GLP 1 Patches Work?

7.7% 27

Doctor-led weight care across India.

Key players in Chiles GLP-1 segment: Novo Nordisk Market leader with Ozempic, Victoza, and Wegovy Eli Lilly Bringing innovation with Mounjaro (Tirzepatide) Sanofi Providing Soliqua, a GLP-1 + insulin combo CFR Pharmaceuticals (Abbott) Local affiliate with strong market access Biocon Expanding biosimilar reach in Latam AstraZeneca Strategic focus on metabolic & cardiovascular synergy With increasing physician adoption and patient demand, Chile is evolving into a high-opportunity market for obesity and type 2 diabetes therapies

Each ingredient in the formulation was meticulously-chosen for its bioavailability, effectiveness and clinical substantiation

Rotate your injection spot every week